Liquidia (LQDA) Shares Outstanding (Weighted Average) (2019 - 2026)
Liquidia (LQDA) recorded quarterly Shares Outstanding (Weighted Average) of $88.0 million in Q1 2026, up 186821.21% quarter-over-quarter from $47082.0 in Q4 2025, and up 3.33% on a YoY basis from $85.2 million in Q1 2025.
Liquidia (LQDA) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends
Liquidia's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $88.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 3.33% year-over-year to $88.0 million; the TTM figure through Mar 2026 stood at $88.0 million (up 3.33% YoY), while the FY2025 annual figure was $47082.0, down 99.94% from the prior year.
- Shares Outstanding (Weighted Average) was $88.0 million for Q1 2026 at Liquidia, up from $47082.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $88.0 million in Q1 2026 to a low of $47082.0 in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $54.7 million across 5 years, with a median of $64.8 million in 2023.
- Biggest YoY gain for Shares Outstanding (Weighted Average) was 132340.13% in 2025; the steepest drop was 99.94% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $61.0 million in 2022, then rose by 6.62% to $65.0 million in 2023, then grew by 21.1% to $78.7 million in 2024, then tumbled by 99.94% to $47082.0 in 2025, then surged by 186821.21% to $88.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $88.0 million (Q1 2026), $47082.0 (Q4 2025), and $85.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.01 Mn |
| Dec 31, 2025 | 47,082.00 |
| Sep 30, 2025 | 85.70 Mn |
| Jun 30, 2025 | 85.59 Mn |
| Mar 31, 2025 | 85.17 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 64,624.00 |
| Mar 31, 2024 | 75.39 Mn |
| Dec 31, 2023 | 64.99 Mn |
| Sep 30, 2023 | 64.86 Mn |
| Jun 30, 2023 | 64.79 Mn |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 60.96 Mn |
| Sep 30, 2022 | 59.75 Mn |
| Jun 30, 2022 | 62.18 Mn |
| Mar 31, 2022 | 52.47 Mn |
| Dec 31, 2021 | 49.68 Mn |
| Sep 30, 2021 | 52.08 Mn |
| Jun 30, 2021 | 47.17 Mn |